نتایج جستجو برای: peripheral blood stem cell transplantation

تعداد نتایج: 2490817  

Journal: :international journal of hematology-oncology and stem cell research 0
vahid zamanzadeh phd, mscn, bscn (associate professor) nursing and midwifery faculty, tabriz university of medical sciences, tabriz, iran. leila valizadeh phd, mscn, bscn (assistant professor) nursing and midwifery faculty, tabriz university of medical sciences, tabriz, iran. leila sayadi phd candidate, mscn, bscn, student in nursing, students' research committee, nursing & midwifery faculty, tabriz university of medical sciences, tabriz, iran. fariba taleghani phd, mscn, bscn (associate professor) nursing and midwifery care research center, nursing and midwifery faculty, isfahan university of medical sciences, isfahan, iran. alireza jeddian phd, md, hematology-oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran.

background: this study explored the state of hematopoietic stem cell transplantation (hsct) recipient patients and problems experienced by them and nurse about these state and problems, in iran. methods: qualitative content analysis was used for analyzing semi-structured interviews with 12 hsct recipient patients and 18 nurses. results: three main categories described the hsct state and problem...

Journal: :iranian journal of blood and cancer 0

hematopoietic stem cell transplantation (hsct) has been practiced for more than 30 years. hematological malignanciesare the main indications for this treatment. however, its indications in adults are different from children.advances in chemotherapy and target therapy have improved treatment outcome of some of the very high riskcancers, and changed indications of hsct in children. multi-center c...

Journal: :the journal of tehran university heart center 0
mojtaba salarifar tehran heart center, medical sciences/university of tehran, tehran, iran. kamran ali moghaddam shariati hospital, medical sciences/university of tehran, tehran, iran. seyed ebrahim kassaian tehran heart center, medical sciences/university of tehran, tehran, iran. mohammad alidoosti tehran heart center, medical sciences/university of tehran, tehran, iran. ali mohammad haji zeinali tehran heart center, medical sciences/university of tehran, tehran, iran. hakimeh sadeghian tehran heart center, medical sciences/university of tehran, tehran, iran.

background: early clinical investigations indicate that an infusion of autologous bone-marrow cells into the infarct-related coronary artery is feasible after acute myocardial infarction. there is increasing evidence that cell transplantation may improve the perfusion and contractile function of the ischemic myocardium . the present study reports primarily the safety of intracoronary bone marro...

Journal: :international journal of hematology-oncology and stem cell research 0
leila sayadi phd candidate, school of nursing and midwifery, tabriz university of medical sciences,tabriz, iran. fateme jafaraghaee phd candidate, school of nursing and midwifery, tehran university of medical sciences, tehran, iran. alireza jeddian md, hematology-oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran. mahboobe kafaei atrian msc, school of nursing and midwifery, kashan university of medical science, kashan, iran. azam akbari msc nursing, guilan university of medical sciences, school of nursing and midwifery, guilan, iran. farhood tootoonchian md, hematology-oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran.

background: today, hematopoietic stem cells transplantation (hsct) has been accepted as a therapeutic approach and is widely applied in many patients with disorders of hematopoietic systems or patients with malignancies. concomitant use of this therapeutic approach with long term chemotherapeutic procedures and hospitalization requires special care. this study was conducted to examine basic nee...

Journal: :avicenna journal of medical biotechnology 0

spermatogonia are the male germ line stem cells whose life long expansion is needed for permanent production of spermatozoa. the present study was designed to examine the effect of hcg treatment on germ cell proliferation following stem cell transplantation in mice. spermatogonial stem cells were isolated from neonatal mice testes and characterized by alkaline phosphatase, immunoreactivity and ...

Journal: :Blood 2010
Pietro Sodani Antonella Isgrò Javid Gaziev Paola Polchi Katia Paciaroni Marco Marziali Maria Domenica Simone Andrea Roveda Aldo Montuoro Cecilia Alfieri Gioia De Angelis Cristiano Gallucci Buket Erer Giancarlo Isacchi Francesco Zinno Gaspare Adorno Alessandro Lanti Lawrence Faulkner Manuela Testi Marco Andreani Guido Lucarelli

Fetomaternal microchimerism suggests immunological tolerance between mother and fetus. Thus, we performed primary hematopoietic stem cell transplantation from a mismatched mother to thalassemic patient without an human leukocyte antigen-identical donor. Twenty-two patients with thalassemia major were conditioned with 60 mg/kg hydroxyurea and 3 mg/kg azathioprine from day -59 to -11; 30 mg/m(2) ...

2017
Kaifeng Liu Hongtao Yu Chenwang Zhang Chunhui Zhu

This study reports the treatment effect of CD133 stem cell transplantation using a corpus cavernosum angiographic surgical technique. We recruited 17 volunteers with Erectile Dysfunction (ED). The umbilical cord and peripheral blood stem cells were simultaneously isolated and collected. The peripheral blood stem cells were collected from the patient’s biological progeny by mobilization with gra...

Journal: :Haematologica 2010
Theo de Witte Anne Hagemeijer Stefan Suciu Amin Belhabri Michel Delforge Guido Kobbe Dominik Selleslag Harry C Schouten Augustin Ferrant Harald Biersack Sergio Amadori Petra Muus Joop H Jansen Eva Hellström-Lindberg Tibor Kovacsovics Pierre Wijermans Gert Ossenkoppele Alois Gratwohl Jean-Pierre Marie Roel Willemze

BACKGROUND Allogeneic stem cell transplantation is usually considered the only curative treatment option for patients with advanced or transformed myelodysplastic syndromes in complete remission, but post-remission chemotherapy and autologous stem cell transplantation are potential alternatives, especially in patients over 45 years old. DESIGN AND METHODS We evaluated, after intensive anti-le...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید